HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tranylcypromine reduces herpes simplex virus 1 infection in mice.

Abstract
Herpes simplex virus 1 (HSV-1) infects the majority of the human population and establishes latency by maintaining viral genomes in neurons of sensory ganglia. Latent virus can undergo reactivation to cause recurrent infection. Both primary and recurrent infections can cause devastating diseases, including encephalitis and corneal blindness. Acyclovir is used to treat patients, but virus resistance to acyclovir is frequently reported. Recent in vitro findings reveal that pretreatment of cells with tranylcypromine (TCP), a drug widely used in the clinic to treat neurological disorders, restrains HSV-1 gene transcription by inhibiting the histone-modifying enzyme lysine-specific demethylase 1. The present study was designed to examine the anti-HSV-1 efficacy of TCP in vivo because of the paucity of reports on this issue. Using the murine model, we found that TCP decreased the severity of wild-type-virus-induced encephalitis and corneal blindness, infection with the acyclovir-resistant (thymidine kinase-negative) HSV-1 mutant, and tissue viral loads. Additionally, TCP blocked in vivo viral reactivation in trigeminal ganglia. These results support the therapeutic potential of TCP for controlling HSV-1 infection.
AuthorsHui-Wen Yao, Pin-Hung Lin, Fang-Hsiu Shen, Guey-Chuen Perng, Yuk-Ying Tung, Sheng-Min Hsu, Shun-Hua Chen
JournalAntimicrobial agents and chemotherapy (Antimicrob Agents Chemother) Vol. 58 Issue 5 Pg. 2807-15 (May 2014) ISSN: 1098-6596 [Electronic] United States
PMID24590478 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Tranylcypromine
  • Thymidine Kinase
Topics
  • Animals
  • Cell Line
  • Cell Proliferation (drug effects)
  • Chlorocebus aethiops
  • Flow Cytometry
  • Herpes Simplex (drug therapy, metabolism, virology)
  • Herpesvirus 1, Human (drug effects, pathogenicity)
  • Humans
  • Mice
  • Real-Time Polymerase Chain Reaction
  • Thymidine Kinase (metabolism)
  • Tranylcypromine (pharmacology)
  • Vero Cells

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: